Staff Scientist
Danaher Corporation
Summary
The Staff Scientist is responsible for leading the design, optimization, and translation of novel real time PCR and RT-PCR IVD assays – from concept to clinical validation – with a focus on microbial targets. Drive data-integrated development to accelerate regulatory success and market readiness. This position is part of the Biochip R&D Unit and will be located in Sunnyvale, CA.
Job description
In this role, you will have the opportunity to:
- Lead, design and execute complex experiments including data collection, summary, and critical analysis to meet project, department, and company objectives.
- Apply analytical problem-solving skills and strategies for the development of complex in vitro diagnostic real time PCR and RT-PCR tests for infectious diseases. Perform rigorous analytical studies required to demonstrate technical feasibility of complex assays.
- Drive product development by communicating and providing actionable data. Establishes product specifications for manufacturing and product claims.
- Provide data driven direction and guidance to junior scientific colleagues.
The essential requirements of the job include:
- PhD in a Biological Science field (e.g. Microbiology, Molecular Biology, Genetics, Biochemistry, Bioengineering, Chemistry, or a related field) with 5+ years of industry related experience or academic equivalent.
- Spearhead feasibility, optimization, verification and validation of molecular diagnostic assays targeting human pathogens. Experience working with microorganisms involved in infectious diseases.
- Ability to balance multiple studies and priorities at the same time with experience in synthesizing and interpreting large-scale experimental data (NGS, qPCR) with clinical trial outcomes to define performance claims.
- Orchestrate 3-5 concurrent studies across assay development, transfer, and clinical evaluation phases. Mitigate bottlenecks through proactive resource allocation and cross-functional coordination (e.g. QA, Engineering, Production, Manufacturing and Clinical Affairs).
- Experience in performing nucleic acid extraction/purification, handling microbiological and clinical specimens, and working in a BSL-2 environment.
It would be a plus if you also possess previous experience in:
- Minimum of 5 years industry experience, with a preference for experience in medical devices or IVD diagnostics.
- Being a part of an NPD team that has successfully launched an FDA cleared molecular diagnostic test.
- Knowledge of product development lifecycle process and design control (Technical Feasibility and Design & Development phases, phase gate exits). Experience implementing and following robust design control processes for CE, US-IVD, and RoW tests.
Requirements
- PhD in a Biological Science field (e.g. Microbiology, Molecular Biology, Genetics, Biochemistry, Bioengineering, Chemistry, or a related field)
- 5+ years of industry related experience or academic equivalent
- Experience in feasibility, optimization, verification and validation of molecular diagnostic assays targeting human pathogens
- Experience working with microorganisms involved in infectious diseases
- Ability to balance multiple studies and priorities
- Experience synthesizing and interpreting large-scale experimental data (NGS, qPCR) with clinical trial outcomes
- Experience orchestrating 3-5 concurrent studies across assay development, transfer, and clinical evaluation phases
- Experience with cross-functional coordination (QA, Engineering, Production, Manufacturing, Clinical Affairs)
- Experience performing nucleic acid extraction/purification
- Experience handling microbiological and clinical specimens
- Experience working in a BSL-2 environment
Benefits
- Paid time off
- Medical, Dental & Vision
- 401(k)
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.